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Background
Incidence of HIV-associated tuberculosis (TB) co-infec-
tion is increasing in Krasnoyarsk region as well as in RF.
Total number of registered TB/HIV new cases has
increased from 7 in 2000 to 170 in 2009. Mortality rate
of patients with HIV/TB co-infection has increased:
2004-7 cases, 2008-40, 2009-48. On January 1st, 2010
we have 407 TB/HIV co-infected patients, which makes
6% from the HIV+ patients under supervision (n=6801)
in our region.
Methods
A retrospective chart review was conducted on HIV-
positive patients diagnosed with TB in 2009. All patients
were HIV-positive and had confirmed diagnosis of
mycobacterial tuberculosis, or clinically presumptive
diagnosis of TB with response to anti-tuberculosis
therapy.
Summary of results
A total of 170 HIV/TB co-infection patients were identi-
fied. The general characteristics of the patients are: male
(75%), median age 28 years old [1;55] when HIV has
been diagnosed and 33 years old [5;56] at the time of
TB diagnosis. HIV was acquired vertically - 0,6%, sexu-
ally in 22% of the cases, and through intravenous drug
injections - 74%. At the time of TB diagnosis, 70 (40%)
had a CD4 count of less than 200. 23% had a baseline
HIV viral load greater than 100,000 copies/ml, median
VL were 338787 copies/ml. 9,4% of cases had a history
of TB prior to HIV diagnosis. 14% had TB as the pri-
mary AIDS-defining event; 82 patients (48%) had
pulmonary disease, 47 patients (28%) presented with
extra-pulmonary disease and of these, 22 (13%) had dis-
seminated disease. 28% cases had extra-pulmonary TB
involvement and are related to lower CD4 count (med-
ian 189/uL vs. 388/µL, p<0.001), and mortality rate. 28
patients (16,5%) had multi-drug resistant TB. 16,5%
patients received antiretroviral treatment (ARV) at the
time of TB diagnosis. Anti-TB treatment was associated
with ARV on 39% (6% PI and 33% NNRTI). Out of 170
HIV/TB patients 35 (21%) were died. Risk of death is
related to severity of immunosuppression and TB diag-
nostic time (median CD4 count 353 in survivors vs 79
in dead, p<0.001). The chronic hepatitis C was found in
69% of patients with HIV/TB infections.
Conclusions
1. HIV/TB co-infection has a high incidence rate due to
delayed verification of TB infection, as a result the prog-
nosis is poor; 2. Risk factors for such patients are low
CD4 cell count and extra-pulmonary involvement; 3.
The high prevalence of the chronic hepatitis C causes
the hepatotoxicity increasing during ART and antituber-
cular therapy for patients with HIV/TB infections.
Published: 8 November 2010
doi:10.1186/1758-2652-13-S4-P193
Cite this article as: Chaychuk et al.: Epidemiology of HIV-associated
tuberculosis (TB) co-infection in Krasnoyarsk region, Russian Federation.
Journal of the International AIDS Society 2010 13(Suppl 4):P193.
Regional Center of AIDS Prevention, consultative and treatment of patients
with HIV, Krasnoyarsk, Russian Federation
Chaychuk et al. Journal of the International AIDS Society 2010, 13(Suppl 4):P193
http://www.jiasociety.org/content/13/S4/P193
© 2010 Chaychuk et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.